The TRACTION trial—co-led by CancerCare Manitoba researchers presented yesterday at #ASH2025.
Findings from 8,400 patients show pre-op tranexamic acid reduces blood transfusion with no increase in blood clots, even in cancer patients. A major step towards safer surgeries and sustainable blood supply
A recent study from our team confirms that isatuximab, a common myeloma treatment— can now be safely delivered in just 30 minutes instead of 75 minutes.
Why it matters: quicker appointments, more comfortable experiences, and more capacity to care for Manitobans.
#patientcare #cancercare
🎓 Exciting news! #PROMISE Madox's Warriors Graduate Studentship officially launches today! Check out the details and help spread the word. #MadoxsWarriors #GradStudentship #CHRIM #CCMB #CancerResearch @um-radyfhs.bsky.social @umbmg.bsky.social @cancercaremb.bsky.social @chrimanitoba.bsky.social
28.11.2025 20:22 — 👍 9 🔁 4 💬 0 📌 1
Dr. Banerji and her lab team holding a banner that says, "Believe"
🍁Meet the Team Canada of Cancer Research: A Q&A with Dr. Versha Banerji🍁
After early setbacks, Dr. Banerji found her calling in hematology. Through MOHCCN, she and her team study immune dysfunction in chronic lymphocytic leukemia to develop more targeted cancer therapies.
tinyurl.com/bdf7w8cv
We are pleased to welcome Dr. Kent Stobart as CancerCare Manitoba’s new President and CEO. A pediatric oncologist and a health care leader, Dr. Stobart brings passion, experience, and a commitment to advancing cancer care and research for all Manitobans. 💙
10.11.2025 19:48 — 👍 4 🔁 0 💬 0 📌 0